News & Press Releases

Mintz advised the underwriters in connection with NervGen Pharma’s $60 million public offering of common shares and accompanying warrants.

Mintz advised Needham & Company, LLC, as representative of the underwriters, in connection with the $315 million initial public offering (IPO) of Berto Acquisition Corp. II, a special purpose acquisition company (SPAC).

Mintz advised the underwriters in connection with Assembly Biosciences’ $115 million underwritten offering of common stock and pre-funded warrants.

The Daily Journal recently named Siegmund "Sige" Gutman, Chair of the firm’s Life Sciences Litigation Practice and Co-chair of its Patent Litigation and Life Sciences practices, to its 2026 “Top Intellectual Property Lawyers” list, which honors leading California-based IP attorneys across patent, trademark, and copyright law.

Michelle Capezza was quoted in a Fiduciary News article examining what the dot-com crash can teach 401(k) fiduciaries about today’s AI-driven stock market surge.

Joshua N. Rudin, Co-chair of Mintz’s Digital Infrastructure Practice, was quoted in an article by Bisnow exploring how the surge in hyperscale data center development may be giving way to increased demand for smaller, strategically located facilities driven by AI inference workloads and evolving infrastructure needs.